Use access key #2 to skip to page content.

becon800 (99.81)

Hemispherx Biopharma, Inc.

Recs

4

February 08, 2009 – Comments (0) | RELATED TICKERS: HEB

HEB could receive approval for a chronic fatigue syndrom drug on 2/25/09. The product has Orphan Drug Status which provides great protection from generics and allows for positive pricing power.

0 Comments – Post Your Own

Featured Broker Partners


Advertisement